Annual report pursuant to Section 13 and 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Revenues $ 203,640 $ 6,500
Operating expenses:    
Research and development 860,533 353,398
Occupancy 57,530 9,500
Depreciation & amortization 12,298 9,446
Officer compensation 237,209
Professional fees 440,007 1,000
Other operating expenses 48,371 13,074
Total operating expenses 1,655,948 386,418
Loss from operations (1,452,308) (379,918)
Other income (expense):    
Gain on sale of assets 180,248
Change in fair value of derivative (2,094,319)
Interest income 3
Interest expense (10,399) (1,817)
Total other income (expense) (1,924,467) (1,817)
Loss before income taxes (3,376,775) (381,735)
Income tax expense
Net loss (3,376,775) (381,735)
Accretion on Series A preferred stock (1,500,004)
Net loss attributed to common shareholders $ (4,876,779) $ (381,735)
Basic net loss per common share $ (0.12) $ (0.01)
Diluted net loss per common share $ (0.12) $ (0.01)
Basic weighted average common shares outstanding 41,981,212 41,400,000
Diluted weighted average common shares outstanding 41,981,212 41,400,000